Popular Searches
Useful Links
Innovation and New Product Development Case Study




Case Title:
Dr. Reddy's Laboratories: On the New Drug Discovery Trail
Publication Year : 2004
Authors: B N Renuka Prasad, G Srikanth
Industry: Health Care
Region:India
Case Code: IPD0012
Teaching Note: Not Available
Structured Assignment: Not Available
Abstract:
With India's imminent shift from process patent regime to product patent regime, post 2005, a host of top Indian drug firms such as Dr. Reddy's, Ranbaxy, Wockhardt, Lupin Laboratories and others, realised the need to do their own drug-discovery research. Dr. Reddy's, one of the leading players in the Indian pharmaceutical industry, is also one of the leading Active Pharmaceutical Ingredient (API) and generics players in the top pharma markets of the world. It has also challenged and won a lawsuit against the world's leading pharmaceutical company, Pfizer, for norvasc (the world's top-selling hypertension medicine) with its generic version. The company, after being successful in its API and generic business, is heading towards new drug discovery. By 2007, the company intends to be among the top 50 global pharmaceutical companies and by 2013 among the top 25.
Pedagogical Objectives:
- To discuss the impact of a product patent regime on the top drug manufacturers in India
- To analyse Dr. Reddy's strategy of heading towards new drug discovery and being a discovery-led global pharmaceutical company.
Keywords : Dr. Reddy's Laboratories Limited; Ranbaxy Laboratories Limited; Drug discovery; Research and development; Indian pharmaceutical industry; Novartis; Active pharmaceutical ingredients; Pfizer, Inc.; Generic drugs; Bulk active pharmaceuticals; Branded generics; Innovation Management Case Study; Specialty pharmaceutical; United States Food and Drug Administration; New drug application; Abbreviated new drug application
Contents:
- Introduction
- Dr. Reddy's: Small beginnings
- Dr. Reddy's: Drug discovery
- Challenges
Related Case Studies
Recently Bought Case Studies

Managing Innovation - Vol. I
Price: $50
Hardcover edition
ISBN 81-314-0603-2India Inc.: Going Global
Price: $50
Hardcover edition
ISBN 978-81-314-2038-6Change Management
Price: $50
Hardcover edition
ISBN 978-81-314-1483-5- View all Casebooks »
Case Studies On
Course Case Mapping For Financial Management - I
Price: $Course Case Mapping For Financial Management - I
Hardcover editionCourse Case Mapping For Quantitative Methods
Price: $Course Case Mapping For Quantitative Methods
Hardcover editionCourse Case Mapping For Marketing Management - I
Price: $Course Case Mapping For Marketing Management - I
Hardcover edition- View All Course Casemaps»
Course Case Mapping For
An Interview with Personnel of Vaatsalya Group
Price: $Vaatsalya Hospitals (B): The Operational ModelAn interview with Dr. Ashwin Naik & Dr. Veerendra Hiremath
Price: $Vaatsalya Hospitals (A): The Business ModelAn Interview with Dr.Rajiv Malhotra & (Prof)Dr.M.P.Sharma
Price: $Managing a World-Class Hospital: The Rockland Story- View all Video Interviews»
Video Interviews
Training and Development
Executive Brief with Anjali Mukherjee
Highly Recommended for Human Resource Management / Training and Development CourseYou Can't Play by Rules, Always
Executive Brief with R.D. Prasad, Product Manager.
Highly Recommended for Organizational Behavior CourseNew Recruit MBAs Attitudes
Executive Brief with Lopamudra Ray, Keya Gupta and Deepika Lingala.
Highly Recommended for Organizational Behavior Course- View all Executive Briefs»
Executive Brief
Geoffrey Moore
Managing Director at TCG Advisors and a Venture Partner at Mohr Davidow Ventures.
Speaks on InnovationMichael Treacy
Co-founded GEN3 Partners.
Speaks on InnovationSam Kogan
President & Chief Operating Officer of GEN3 Partners.
Speaks on Innovation- View All Executive Interviews»